The ultimate goal of drug delivery is to increase the bioavailability and reduce the toxic side
effects of the active pharmaceutical ingredient (API) by releasing them at a specific site of …

The delivery of chemotherapeutics to solid tumors using smart drug delivery systems
(SDDSs) takes advantage of the unique physiology of tumors (ie, disordered structure, leaky …

Liposomes are amphipathic lipidic supramolecular aggregates that are able to encapsulate
and carry molecules of both hydrophilic and hydrophobic nature. They have been widely …

Site-specific delivery of the therapeutic agents to the target site is the most challenging and
most important goal from the clinical point of view. Recently, much effort has been indulged …

Liposomes are well-known nanoparticles with a non-toxic nature and the ability to
incorporate both hydrophilic and hydrophobic drugs simultaneously. As modern drug …

Introduction: Long circulating liposomal drug carriers are widely used in experimental
cancer therapy because they avoid excretion and benefit from the enhanced permeability …

Liposomes are known to be promising nanoparticles (NPs) for drug delivery applications.
Among the different types of self-assembled NPs, liposomes stand out for their non-toxic …

The site-specific delivery of antitumor agents is of importance for providing effective cancer
suppression. Poor bioavailability of anticancer compounds and the presence of biological …

Nanotechnology has recently gained lots of interest in drug delivery due to its potential to
improve the therapeutic outcomes of various diseases. Particularly, a wide range of different …

Tumor specific drug delivery has become increasingly interesting in cancer therapy, as the
use of chemotherapeutics is often limited due to severe side effects. Conventional drug …